Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supportive versus immunosuppressive therapy for progressive IgA nephropathy
2007-000871-41Phase 3Completed
- Sponsor
- RWTH Aachen University
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azathioprine, cyclophosphamide, prednisolone and methylprednisolone in IgA nephropathy (IgAN) (2 arms), sponsored by RWTH Aachen University. Primary endpoints: Full clinical remission and Renal function decline. Started Nov 2007; status: completed.
02
Drugs
azathioprinecyclophosphamideprednisolonemethylprednisolone
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on 2007-000871-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000871-41.